My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidlines Journals & Publications Policy & Advocacy Meetings About IDSA
September 2008
Vol. 18, No. 9
Global ID
Q Fever in Holland

Dutch health authorities have reported 660 cases of Q fever this year, according to the U.S. Centers for Disease Control and Prevention (CDC). The outbreak is centered in the southern part of the country. A sharp increase in cases occurred in May. Last year also saw an outbreak of Q fever in Holland, with most cases occurring between May and July.

Q fever is caused by Coxiella burnetii, most often carried by goats, sheep, or cattle. Patients contract Q fever by inhaling contaminated dust or soil, or by consuming unpasteurized dairy products. Patients generally become ill two to five weeks after exposure. About half of those infected develop symptoms, including fever, chills, sweats, severe headache, muscle aches, abdominal pain, chest pain, sore throat, non-productive cough, vomiting, diarrhea, and malaise. One-third to one-half of patients will develop pneumonia. Liver function may be affected and hepatitis may develop. The disease is fatal in 1 to 2 percent of cases.

The more serious, chronic form of the disease is uncommon but may lead to endocarditis. Chronic Q fever is fatal in 65 percent of cases. Most of those who develop chronic Q fever have pre-existing valvular heart disease or have received a vascular graft.

Serologic testing or DNA detection are recommended for diagnosing Q fever. Doxycycline is the drug of choice to treat it. More information on the outbreak is available on CDC’s Travelers’ Health website.
How useful is this article?

< Previous Article | Next Article >

Post a comment

Your name:

Your comment:


Cover Stories
CDC Campaigns Target MRSA, Inappropriate Antibiotic Use
2009 Clinical Practice Meeting in San Diego
IDSA Journal Club, August 2008
From the President
IDSA Ascendant
Patient Care and Science
EIN: Difficulty Treating Multidrug-resistant Gram Negative Infections
Drug Approvals, Recalls, Adverse Events Update
In the IDSA Journals
Practice Management
ID Physicians Have Second-highest Coding Error Rate in CMS Report
Global ID
IDSA, HIVMA Launch Infectious Diseases Center for Global Health Policy and Advocacy
Chikingunya Fever in Italy, Singapore
Q Fever in Holland
Polio Resurges in Nigeria After a Promising Year
Yellow Fever in Côte d'Ivoire
Policy and Advocacy
IDSA and HIVMA Urge Presidential Candidates to Put Science Before Politics
IDSA Advocacy Update
Education and Resources
Two New Training Grants Available For Global Research
Your Colleagues
In Memoriam: Thomas Weller
Members on the Move
Welcome, New IDSA Members!

IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'idsa@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.